Category: Pharmacology & Therapeutics
Keywords: clindamycin, MRSA, SSTI (PubMed Search)
Clindamycin used to be a first-line agent for many SSTIs, particularly where MRSA was suspected. With growing resistance to staph species, the 2014 IDSA Guidelines recommend clindamycin as an option only in the following situations:
* Clindamycin may be used if clindamycin resistance is <10-15% at the institution.
Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59(2):e10-52. [PMID 24947530]
Follow me on Twitter (@PharmERToxGuy) or Google Plus (+bryanhayes13)